Day2
06/07 08:00-17:10
Main Hall
-
08:00-09:00Session 1 TAVR Decision-Making: How Should I Treat?
-
08:00-09:00Moderators
-
08:00-09:00
-
08:00-09:00Online Panelists
-
08:00-08:02Opening
-
Case 1
-
08:02-08:07Bicuspid aortic valve – Dilemma during TAVR
-
08:07-08:13How would I treat this case?
-
08:13-08:19Discussion
-
08:19-08:24How did I treat?
-
08:24-08:30Discussion
-
Case 2
-
08:30-08:35Redo TAVR in self-expanding valve failure
-
08:35-08:41How would I treat this case?
-
08:41-08:47Discussion
-
08:47-08:52How did I treat?
-
08:52-08:58Discussion
-
08:58-09:00Wrap up
-
09:00-10:30Session 2 Live Transmission session III
-
09:00-10:30Moderators
-
09:00-10:30
-
09:00-10:30Online Panelists
-
09:00-09:40Case 5: MTEER Cheng Hsin General Hospital (振興醫院)
-
09:40-10:20Case 6: Lux valve for TR Xiamen Cardiovascular Hospital Xiamen University(廈門大學附屬心血管病醫院)
-
10:20-10:30Mitral TEER (PASCAL and MitraClip) for degenerative MR, moderate MR
-
10:30-11:37Session 3 Roundtable discussion-Leaflet Modification During TAVI / ViV / Redo TAVI
-
10:30-11:37Moderators
-
10:30-11:37
-
10:30-10:33Introduction
-
10:33-10:43TS MViV: Tip-to-base LAMPOON
-
10:43-10:49Discussion
-
10:49-10:59Redo TAVR using BASILICA
-
10:59-11:05Discussion
-
11:05-11:15Valve-in-Valve TAVR with UNICORN
-
11:15-11:21Discussion
-
11:21-11:31Why UNICORN Failed? The importance of intra-leaflet deployment
-
11:31-11:37Discussion
-
11:37-12:50Session 4 Transcatheter tricuspid valve intervention
-
11:37-12:50Moderators
-
11:37-12:50Online Moderator
-
11:37-12:50
-
11:37-12:50Online Panelists
-
11:37-11:40Introduction
-
11:40-11:50Tricuspid TEER vs TTVR: How to Decide for my Patient?
-
11:50-11:54Discussion
-
11:54-12:04CIED-related TR: Prevention & Management
-
12:04-12:08Discussion
-
12:08-12:18Advanced strategies and device selection for torrential TR with large coaptation gap
-
12:18-12:22Discussion
-
12:22-12:32Transcatheter ectopic tricuspid valve implantation (CAVI): Who, When and How?
-
12:32-12:36Discussion
-
12:36-12:46Case sharing – Zipping vs. Clover in tricuspid TEER
-
12:46-12:50Discussion
-
12:50-14:03Session 5 TAVI Beyond the Comfort Zone: Complex Anatomy and Bail-Out Strategies
-
12:50-14:03Moderators
-
12:50-14:03Panelists
-
12:50-14:03Online Panelists
-
12:50-12:53Opening
-
12:53-13:05Is TAVI applicable to aortic insufficiency? current device technologies and evidence
-
13:05-13:17Outcomes of second valve implantation as a bail-out strategy for acute valve migration during TAVR
-
13:17-13:29What should we consider after aortic fixation of an embolized THV? Insights from CT flow–based analysis."
-
13:29-13:41Bicuspid aortic valve leaflet modification before TAVR
-
13:41-13:53At the Crossroads: Transforming TAVR from a safe and doable Procedure towards Precision Medicine
-
13:53-14:03Panel discussion
-
14:03-14:58Session 6 Live Transmission session IV
-
14:03-14:58Moderators
-
14:03-14:58
-
14:03-14:38Case 7: TAVR Cheng Hsin General Hospital (振興醫院)
-
14:38-14:48CT planning in valve interventions
-
14:48-14:58ICE-guided TAVI- Experience sharing from Severance Cardiovascular Hospital, Yonsei University Health System
-
14:58-15:58Session 7 Pulmonary artery denervation (PADN): From Mechanism to Clinical Application
-
14:58-15:58Moderators
-
14:58-15:58
-
14:58-15:58Online Panelists
-
14:58-15:00Opening
-
15:00-15:20Pulmonary Artery Denervation (PADN) — Mechanism, Evidence, and Patient Selection
-
15:20-15:35PADN- Tips and tricks and trouble shooting
-
15:35-15:47New treatment strategy for pulmonary hypertension beyond PADN
-
15:47-15:58Discussion
-
15:58-17:00Session 8 Advances in Transcatheter and Surgical Valve Therapy
-
15:58-17:00Moderators
-
15:58-17:00
-
15:58-16:01Introduction
-
16:01-16:13Surgical Aortic Root Enlargement: Strategies in the Era of Lifetime Valve Management
-
16:13-16:25Tricuspid valve replacement
-
16:25-16:37Valve-in-Valve-in-Valve: Learning starts now
-
16:37-16:49SAPIEN 3 Ultra real-world performance in the context of PARTNER 3 long-term outcomes
-
16:49-17:00Discussion
-
17:00-17:10Closing Remarks